People: Athersys Inc (ATHX.OQ)
Dr. John J. Harrington, Ph.D., is Executive Vice President, Chief Scientific Officer, Director of Athersys Inc. Dr. Harrington led the development of the RAGE® technology, as well as its application for gene discovery, drug discovery and commercial protein production applications. He is a listed inventor on over 20 issued or pending United States patents, has authored numerous scientific publications, and has received numerous awards for his work, including being named one of the top international young scientists by MIT Technology Review in 2002. Dr. Harrington has overseen the therapeutic product development programs at Athersys since their inception, and is also focused on the clinical development and manufacturing of MultiStem®. During his career, he has also held positions at Amgen and Scripps Clinic. He earned his B.A. in Biochemistry and Cell Biology from the University of California at San Diego and his Ph.D. in Cancer Biology from Stanford University.
|Total Annual Compensation, USD||462,015|
|Restricted Stock Awards, USD||88,862|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||177,713|
|Fiscal Year Total, USD||728,590|